rs773723931

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000222.3(KIT):​c.1137A>G​(p.Leu379Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,612,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L379L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000041 ( 0 hom. )

Consequence

KIT
NM_000222.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.376

Publications

2 publications found
Variant links:
Genes affected
KIT (HGNC:6342): (KIT proto-oncogene, receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase. This gene was initially identified as a homolog of the feline sarcoma viral oncogene v-kit and is often referred to as proto-oncogene c-Kit. The canonical form of this glycosylated transmembrane protein has an N-terminal extracellular region with five immunoglobulin-like domains, a transmembrane region, and an intracellular tyrosine kinase domain at the C-terminus. Upon activation by its cytokine ligand, stem cell factor (SCF), this protein phosphorylates multiple intracellular proteins that play a role in in the proliferation, differentiation, migration and apoptosis of many cell types and thereby plays an important role in hematopoiesis, stem cell maintenance, gametogenesis, melanogenesis, and in mast cell development, migration and function. This protein can be a membrane-bound or soluble protein. Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous leukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2020]
KIT Gene-Disease associations (from GenCC):
  • gastrointestinal stromal tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Ambry Genetics
  • piebaldism
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • cutaneous mastocytosis
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • mastocytosis
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 4-54709445-A-G is Benign according to our data. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54709445-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 415815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.376 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.0000411 (60/1459876) while in subpopulation AMR AF = 0.00132 (59/44722). AF 95% confidence interval is 0.00105. There are 0 homozygotes in GnomAdExome4. There are 27 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 60 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KITNM_000222.3 linkc.1137A>G p.Leu379Leu synonymous_variant Exon 7 of 21 ENST00000288135.6 NP_000213.1 P10721-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KITENST00000288135.6 linkc.1137A>G p.Leu379Leu synonymous_variant Exon 7 of 21 1 NM_000222.3 ENSP00000288135.6 P10721-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152222
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000235
AC:
59
AN:
251444
AF XY:
0.000191
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.0000411
AC:
60
AN:
1459876
Hom.:
0
Cov.:
30
AF XY:
0.0000372
AC XY:
27
AN XY:
726406
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33440
American (AMR)
AF:
0.00132
AC:
59
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39674
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86226
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
9.01e-7
AC:
1
AN:
1110188
Other (OTH)
AF:
0.00
AC:
0
AN:
60320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152222
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41458
American (AMR)
AF:
0.000196
AC:
3
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000642

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Gastrointestinal stromal tumor Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Mar 30, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.9
DANN
Benign
0.41
PhyloP100
-0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773723931; hg19: chr4-55575611; API